Iffe Futura, S.A.

NAT

ES0171613005

Pharmaceuticals

Market Closed - BME Other stock markets 11:35:13 2024-06-28 EDT			5-day change	1st Jan Change
0.645 ^EUR	+5.74%		+0.78%	-11.64%

06-19	Iffe Futura, S.A. agreed to acquire Instituto De Formacion Financiera Y Empresarial, S.L.	CI
2023	Iffe Futura, S.A. Reports Earnings Results for the Half Year Ended June 30, 2023	CI

Promociones Renta Y Mantenimiento Socimi S.A. authorizes a Buyback Plan.

February 20, 2019

The Board of Directors of Promociones Renta Y Mantenimiento Socimi S.A. has authorized a buyback plan on February 21, 2019.

Latest news about Iffe Futura, S.A.

Iffe Futura, S.A. agreed to acquire Instituto De Formacion Financiera Y Empresarial, S.L.	06-18	CI
Iffe Futura, S.A. Reports Earnings Results for the Half Year Ended June 30, 2023	23-10-03	CI
Iffe Futura, S.A. Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-27	CI
Iffe Futura, S.A. Reports Earnings Results for the Half Year Ended June 30, 2022	22-10-23	CI
Iffe Futura, S.A. announced that it expects to receive €9.075 million in funding from Key Wolf, S.L., Inveready Asset Management, S.G.E.I.C., S.A., Inveready Biotech III Parallel Scr SA	22-06-16	CI
Iffe Futura, S.A. Reports Earnings Results for the Full Year Ended December 31, 2021	22-04-28	CI
Iffe Futura, S.A. Reports Earnings Results for the Half Year Ended June 30, 2021	21-10-22	CI
Key Wolf, S.L. signed an irrevocable agreement to acquire 5.3% stake in Iffe Futura, S.A. for €0.86 million.	21-06-23	CI
Inveready Asset Management, S.G.E.I.C., S.A. agreed to acquire 12.2% stake in Iffe Futura, S.A. for €2.9 million.	21-06-22	CI
Iffe Futura, S.A. announced that it expects to receive €2.5 million in funding	21-06-22	CI
Nyesa Valores Corporación, S.A. terminated the acquisition of Iffe Futura, S.A. from David Carro and other shareholders.	21-05-17	CI
Iffe Futura, S.A. Reports Earnings Results for the Full Year Ended December 31, 2020	21-04-29	CI
Nyesa Valores Corporación, S.A. made an offer to acquire Iffe Futura, S.A. from David Carro and other shareholders for €43.9 million.	21-02-21	CI
Iffe Futura, S.A. acquired remaining 50% stake in IFFE BIOTECH for €1.3 million.	20-01-30	CI
Iffe Futura, S.A. acquired Milimex Developments LLC for €1.2 million.	20-01-30	CI
Tranche Update on Promociones Renta Y Mantenimiento Socimi S.A.'s Equity Buyback Plan announced on February 25, 2019.	19-02-24	CI
Promociones Renta Y Mantenimiento Socimi S.A. announces an Equity Buyback for 1,828,170 shares, for €3.66 million.	19-02-24	CI
Promociones Renta Y Mantenimiento Socimi S.A. authorizes a Buyback Plan.	19-02-20	CI
Promociones Renta Y Mantenimiento Socimi S.A.'s Equity Buyback announced on February 25, 2019, has closed with 1,828,170 shares, for €3.66 million.	19-02-20	CI
COMPTES PERKS PFP, S.Ag announced that it has received €0.14 million in funding from Promociones Renta Y Mantenimiento Socimi S.A. and other investors	18-02-27	CI
Promociones Renta Y Mantenimiento Socimi S.A. acquired 99% stake in CUENTAS PARTICIPATIVAS COTIZADAS, S.A.	18-02-04	CI

Iffe Futura SA is a Spain-based company active in the investment industry. The Company is an industrial and financial and education services group. The Companyâs business lines are IFFE Business School, DCM Asesores, IFFE Biotech, IFFE Desarrollos and IF. IFFE Business School offers different post-graduate studies and business preparation. DCM Asesores provides advises to the companies in the process of going to MAB (Alternative Stock Market from Spain). IFFE Biotech is a biotechnology company dedicated to the research, development and production of Omega-3 fatty acids. IFFE Desarrollos develops the real estate operations from the Group. IF is the incubator and accelerator of projects and companies of the IFFE Futura Group.

Sector

Pharmaceuticals

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
IFFE FUTURA, S.A.	-11.64%	300M
ELI LILLY AND COMPANY	+55.32%	815B
NOVO NORDISK A/S	+44.05%	641B
JOHNSON & JOHNSON	-6.75%	352B
MERCK & CO., INC.	+13.56%	314B
ABBVIE INC.	+10.68%	303B
ASTRAZENECA PLC	+16.57%	242B
NOVARTIS AG	+13.31%	218B
AMGEN INC.	+8.48%	168B
PFIZER, INC.	-2.81%	159B